Company Details
charles-river-laboratories
14,752
229,098
541714
criver.com
0
CHA_1163479
In-progress

Charles River Laboratories Company CyberSecurity Posture
criver.comAt Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Company Details
charles-river-laboratories
14,752
229,098
541714
criver.com
0
CHA_1163479
In-progress
Between 750 and 799

CRL Global Score (TPRM)XXXX



No incidents recorded for Charles River Laboratories in 2025.
No incidents recorded for Charles River Laboratories in 2025.
No incidents recorded for Charles River Laboratories in 2025.
CRL cyber incidents detection timeline including parent company and subsidiaries

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions s

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product
.png)
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2025 investor letter.
Charles River Laboratories has continued to underperform the broader market over the past year, yet analysts remain moderately bullish on...
WILMINGTON, Mass., November 17, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it...
Charles River Laboratories' third quarter results were met with negative market reaction, as investors focused on the company's muted...
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented...
Charles River Laboratories International (CRL) shares edged up slightly, with investors watching for updates that could guide the laboratory...
Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on...
Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after the company reported...
Announces Steps to Strengthen and Refine Portfolio and to Maximize Financial Performance –. WILMINGTON, Mass., November 05, 2025--(BUSINESS...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Charles River Laboratories is http://criver.com.
According to Rankiteo, Charles River Laboratories’s AI-generated cybersecurity score is 778, reflecting their Fair security posture.
According to Rankiteo, Charles River Laboratories currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Charles River Laboratories is not certified under SOC 2 Type 1.
According to Rankiteo, Charles River Laboratories does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Charles River Laboratories is not listed as GDPR compliant.
According to Rankiteo, Charles River Laboratories does not currently maintain PCI DSS compliance.
According to Rankiteo, Charles River Laboratories is not compliant with HIPAA regulations.
According to Rankiteo,Charles River Laboratories is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Charles River Laboratories operates primarily in the Biotechnology Research industry.
Charles River Laboratories employs approximately 14,752 people worldwide.
Charles River Laboratories presently has no subsidiaries across any sectors.
Charles River Laboratories’s official LinkedIn profile has approximately 229,098 followers.
Charles River Laboratories is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
No, Charles River Laboratories does not have a profile on Crunchbase.
Yes, Charles River Laboratories maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/charles-river-laboratories.
As of December 11, 2025, Rankiteo reports that Charles River Laboratories has not experienced any cybersecurity incidents.
Charles River Laboratories has an estimated 4,473 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Charles River Laboratories has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.